Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
2.380
+0.143 (6.37%)
May 17, 2024, 4:00 PM EDT - Market closed

Can-Fite BioPharma Market Cap

Can-Fite BioPharma has a market cap or net worth of $10.51 million as of May 17, 2024. Its market cap has increased by 84.45% in one year.

Market Cap
10.51M
Enterprise Value
8.12M
1-Year Change
84.45%
Ranking
Category
Stock Price
$2.38

Market Cap Chart

Since December 31, 2012, Can-Fite BioPharma's market cap has decreased from $37.20M to $10.51M, a decrease of -71.74%. That is a compound annual growth rate of -10.51%.

History

DateMarket Cap% Change
May 17, 202410.80M6.93%
May 16, 202410.10M8.60%
May 15, 20249.30M-4.12%
May 14, 20249.70M-
May 13, 20249.70M2.11%
May 10, 20249.50M-2.06%
May 9, 20249.70M5.43%
May 8, 20249.20M-2.13%
May 7, 20249.40M-2.08%
May 6, 20249.60M1.05%
May 3, 20249.50M3.26%
May 2, 20249.20M-3.16%
May 1, 20249.50M1.06%
Apr 30, 20249.40M5.62%
Apr 29, 20248.90M-1.11%
Apr 26, 20249.00M3.45%
Apr 25, 20248.70M-1.14%
Apr 24, 20248.80M-1.12%
Apr 23, 20248.90M-1.11%
Apr 22, 20249.00M-
Apr 19, 20249.00M1.12%
Apr 18, 20248.90M-
Apr 17, 20248.90M-5.32%
Apr 16, 20249.40M-
Apr 15, 20249.40M-1.05%
View and export this data all the way back to 2012. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Trinity Biotech 12.19M
Chemomab Therapeutics 12.16M
Calidi Biotherapeutics 11.97M
Akso Health Group 11.94M
Elevai Labs 11.87M
Moleculin Biotech 11.70M
Fresh2 Group 11.64M
OneMedNet 11.57M
Market Cap Rankings